This morning, Credit Suisse initiated coverage on shares of Pfizer (NYSE:PFE) with an outperform rating as the company's restructuring efforts will produce long-term value for shareholders. With the outperform rating, Credit Suisse set a $34 price target. Shares of Pfizer were lower this morning, slipping 0.6% so far.
And Mizuho upgraded shares of Cubist Pharmaceuticals (NASDAQ:CBST) from neutral to buy as acquisitions will drive growth in the near term. With the upgrade, Mizuho set a $77 price target. Shares of Cubist were flat on Wednesday, trading right around $61.50 per share.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.